India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

<ul>
<li>Jubilant Ingrevia has launched its "Pinnacle 3.4.5" strategy targeting 3x revenue and 4x EBITDA growth by FY30, signaling a focused shift toward higher-margin segments.</li>
<li>The company’s business mix is rapidly evolving, with Specialty Chemicals and Nutrition now contributing 62% of revenue, improving margin visibility and reducing cyclicality.</li>
<li>With increasing downstream integration, global CDMO expansion, and a robust R&amp;D pipeline, Jubilant Ingrevia is transitioning into a structurally higher-margin, innovation-driven player.</li>
</ul>


Jubilant Ingrevia has launched its "Pinnacle 3.4.5" strategy targeting 3x revenue and 4x EBITDA growth by FY30, signaling a focused shift toward higher-margin segments.
The company’s business mix is rapidly evolving, with Specialty Chemicals and Nutrition now contributing 62% of revenue, improving margin visibility and reducing cyclicality.
With increasing downstream integration, global CDMO expansion, and a robust R&amp;D pipeline, Jubilant Ingrevia is transitioning into a structurally higher-margin, innovation-driven player.


The Beat Ideas: Jubilant Ingrevia-Specialty Formula for Margin Expansion

India

Jubilant Ingrevia Limited is a global integrated life science products and innovative solutions provider. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers with specialty chemicals, nutrition and health solutions, and chemical intermediates. It offers a broad portfolio of high-quality ingredients and provides custom development and manufacturing services for pharmaceutical and agrochemical clients. Jubilant Ingrevia is headquartered in Noida, Uttar Pradesh, India, and was incorporated on October 23, 2019.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jubilant Ingrevia (JUBLINGR IN)

The Beat Ideas: Jubilant Ingrevia-Specialty Formula for Margin Expansion

Jubilant Ingrevia aims for 3x revenue and 4x EBITDA growth by FY30 with a focus on higher-margin segments like Specialty Chemicals and Nutrition,...

Sudarshan Bhandari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

The Beat Ideas: Jubilant Ingrevia-Specialty Formula for Margin Expansion

​Jubilant Ingrevia aims for 3x revenue and 4x EBITDA growth by FY30 with a focus on higher-margin segments like Specialty Chemicals and Nutrition,...

Sudarshan Bhandari

Jubilant Ingrevia aims for 3x revenue and 4x EBITDA growth by FY30 with a focus on higher-margin segments like Specialty Chemicals and Nutrition,...